CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Immudyne Inc Company Snapshot
Immudyne Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Immudyne Inc with three other companies in this sector in the United States: Editas Medicine Inc (2016 sales of $6.05 million of which 100% was Pharmaceutical), Fate Therapeutics Inc ($4.40 million of which 100% was Biopharmaceuticals), and BioTime, Inc. ($5.92 million of which 100% was Synthetic Solutions).

Sales Analysis. Sales increased substantially in 2016: During the year ended December of 2016, sales at Immudyne Inc were $5.24 million. This is an increase of 329.8% versus 2015, when the company's sales were $1.22 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Immudyne Inc
  Stock Performance Chart for Immudyne Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (6/23/2017): .30
(Figures in U.S. Dollars)
1 Week -1.5%   13 Weeks -26.2%  
4 Weeks -49.0%   52 Weeks 5.5%  
 
Immudyne Inc Key Data:
  Ticker: IMMD Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 5,238,604
(Year Ending Jan 2017).
Employees: 14
  Currency: U.S. Dollars Market Cap: 11,342,237
  Fiscal Yr Ends: December Shares Outstanding: 38,406,601
  Share Type: Ordinary Closely Held Shares: 9,582,092
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.